Navigation Links
Free Download: Two Impressive Case Studies on Drug Delivery Discoveries
Date:9/4/2013

SHANGHAI, Sept. 4, 2013 /PRNewswire/ -- Organized by CPhI Conferences, The 3rd NDDS & Clinical Trial Management China 2013, will take place on 27th-28th November at Sheraton HongKou, Shanghai. This year's edition will deliver themes which will drive cross-industry co-operation, highlight the latest market trends, showcase advances in both technique and methodology and provide an effective business networking environment for the conference's participants. The two-day conference will include 3 chapters: Drug discovery and research fulfillments, Novel pathway for future drug delivery solutions and Biotherapeutic drug delivery towards clinical science development. There will be 16 professional presentations and 2 panel discussions, to explore the commercial value, techniques, requirements and clinical science of NDDS. To download the full agenda, please log on to www.ndds-china.com.

Meanwhile, the organizer shared two excellent presentations with us about the medical devices industry. The first one was "Oral controlled release dosage form design and case study" by Andy Lu, the General Manager of Shanghai Aucta Pharmaceuticals Co., Ltd. In his speech, he discussed factors for formulation design, formulation and technology selection, formulation evaluation and a few fantastic case studies as well. The second was "Integration of  Nano-and Amorphous Solid Dispersion Formulations into Drug Discovery", by Yaling Wang, the Basic Pharmaceutical Sciences director of Merck Sharp & Dohme Corp. In her speech, she touched on formulation challenges in drug discovery, enhancement of dissolution/solubility limited exposure, nano-suspension formulation and much more. If you are interested in those topics, please CLICK HERE for a free download.

Please click on the following link if the download was unsuccessful:

http://www.ndds-china.com/Download.aspx?id=16&lang=en-us&source=pr2

Media Contact

Ms. Tracy Cui
Tel: +86-21-6157 3919
Fax:+86-21-6157 7299
Email: tracy.cui@ubm.com  

 

 


'/>"/>
SOURCE CPhI Conferences
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
2. National Pharmaceutical Council Studies New Formulary Decision-Making Tool
3. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
4. Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
5. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
6. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
7. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
8. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
9. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
10. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
11. ImmunGene and Collaborators Report Positive Results in Pre-clinical Studies of Novel Anti-CD20 Antibody-Interferon Alpha Fusion Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):